Brain Stimulation + Physical Therapy for Chronic Knee Pain
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a combination of brain stimulation and physical therapy to determine its effectiveness in reducing chronic knee pain and improving function. The brain stimulation technique, transcranial direct current stimulation (tDCS), targets the brain to potentially reduce pain by altering pain signal processing. Participants will receive either active tDCS or a sham (inactive) version, along with physical therapy sessions. This study is for individuals who have experienced knee pain for over three months and have not undergone surgery on that knee. As an unphased trial, it offers a unique opportunity to explore innovative treatments for chronic knee pain.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that transcranial direct current stimulation is safe for treating chronic knee pain?
Research has shown that transcranial direct current stimulation (tDCS) is generally safe and well-tolerated. Studies have demonstrated that using tDCS at 2 mA for 20 minutes is safe, even for older adults with long-term knee pain. Participants typically do not experience significant side effects. Another study found that combining tDCS with exercise is both safe and practical. Although more information is needed about its safety for people with chronic pain, these findings suggest that tDCS is a promising option without major safety concerns.12345
Why are researchers excited about this trial?
Researchers are excited about the combination of transcranial direct current stimulation (tDCS) and physical therapy for chronic knee pain because it offers a non-invasive approach that targets the brain to manage pain. Unlike standard treatments such as medications and injections that primarily focus on the knee itself, tDCS works by stimulating specific brain regions associated with pain perception, potentially offering relief without the side effects of drugs. Additionally, this method is paired with physical therapy to enhance its effectiveness, providing a holistic approach to pain management. This combination could lead to more targeted and efficient pain relief, making it a promising alternative for those who struggle with chronic knee pain.
What evidence suggests that this trial's treatments could be effective for chronic knee pain?
Research has shown that transcranial direct current stimulation (tDCS) can help manage knee pain. Studies have found that tDCS can reduce pain levels and sensitivity in people with knee osteoarthritis (OA). For instance, applying tDCS to the brain area controlling movement can ease pain and improve walking. In this trial, participants will join either an active tDCS group or a sham tDCS group, both combined with physical therapy. tDCS also shows promise for treating other long-term pain conditions, such as fibromyalgia and nerve pain. These findings suggest that tDCS could be a valuable addition to physical therapy for those with chronic knee pain.26789
Are You a Good Fit for This Trial?
This trial is for adults over 18 who have had knee pain for at least 3 months and haven't had surgery in that area. It's ideal for those scheduled to receive physical therapy but haven't found relief from traditional treatments.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive transcranial direct current stimulation (tDCS) in conjunction with individualized physical therapy for 8 sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Transcranial Direct Current Stimulation
Trial Overview
The study tests if brain stimulation (tDCS) combined with personalized physical therapy can better improve pain and function in chronic knee pain sufferers than fake stimulation with the same therapy.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
For those participants assigned to the active or sham tDCS groups, the overall set-up will be identical between groups and will use the Mini-CT device. However, the sham tDCS group will have the tDCS device turned off after 30 seconds of stimulation. Saline-soaked sponge electrodes that are 35 cm\^2 in size will be used for both the active and sham tDCS groups. For electrode placement, the active electrode (anode) will be placed over M1 contralateral to the side of primary knee pain (over C3/4 using the 10-20 system for electrode placement), while the reference electrode (cathode) will be over the contralateral supraorbital region, which is ipsilateral to the painful knee (Fp2 using the 10-20 system). The intensity will be set at 2mA for the active tDCS group, following a 30 second ramp-up time. The participants in the active tDCS group will undergo 20 minutes of tDCS treatment prior to receiving individualized PT intervention.
For those participants assigned to the active or sham tDCS groups, the overall set-up will be identical between groups and will use the Mini-CT tDCS device. However, the sham tDCS group will have the tDCS device turned off after 30 seconds of stimulation. Saline-soaked sponge electrodes that are 35 cm\^2 in size will be used for both the active and sham tDCS groups. For electrode placement, the active electrode (anode) will be placed over M1 contralateral to the side of primary knee pain (over C3/4 using the 10-20 system for electrode placement), while the reference electrode (cathode) will be over the contralateral supraorbital region, which is ipsilateral to the painful knee (Fp2 using the 10-20 system). The participants in the sham tDCS group will undergo 20 minutes of sham tDCS treatment prior to receiving individualized PT intervention.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor
Published Research Related to This Trial
Citations
Transcranial direct current stimulation enhances the efficacy of ...
Repeated-measures ANOVA indicated that tDCS significantly improved the efficacy of TENS in alleviating pain and enhancing walking ability among ...
Efficacy of transcranial direct current stimulation in patients ...
The results of this review suggest that tDCS holds promise as a pain management intervention for individuals with knee OA. Notably, anodal tDCS applied over the ...
Effects of Transcranial Direct Current Stimulation on pain and ...
Our findings suggest that tDCS might be effective for fibromyalgia, migraine, and neuropathic pain associated with spinal cord injury and stroke ...
4.
bmcmusculoskeletdisord.biomedcentral.com
bmcmusculoskeletdisord.biomedcentral.com/articles/10.1186/s12891-024-07805-3Effects of transcranial direct current stimulation on pain and ...
The results of our meta-analysis showed that tDCS was effective in relieving short-term pain intensity and pain sensitivity in patients with KOA ...
Transcranial Direct Current Stimulation in the Treatment of ...
This scoping review aims to evaluate the efficacy of tDCS in treating chronic knee pain among older adults. Methods: A comprehensive search of peer-reviewed ...
Dosage and safety of transcranial magnetic stimulation and ...
Additionally, safety profiles for these non-invasive brain stimulation interventions in patients with CMP remain insufficiently reported, with ...
Transcranial Direct Current Stimulation in Conjunction with ...
Transcranial direct current stimulation (tDCS) is a form of noninvasive brain stimulation that can have neuromodulatory effects on central nervous system ...
8.
headachejournal.onlinelibrary.wiley.com
headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14887The safety and feasibility of transcranial direct current ...
We found tDCS + ET was safe, feasible, and tolerable. Secondary outcomes suggested active tDCS + ET was superior to sham tDCS + ET when ...
Motor cortex transcranial direct current stimulation effects ...
2 mA for 20 min of anodal tDCS is safe and well tolerated in the elderly. •. tDCS alone did not induce long-term effects in the elderly with knee chronic pain.
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.